From policy to practice: Evaluating the global implications of the FDA's PDURS framework.

Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.

Related documents

• UC Comments on FDA's Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability (Docket No. FDA-2021-D-1214, December 9, 2021)#629324
• A New Global Health Actor? The OECD's Careful Guidance of National Health Care Systems#1160827
• Turkey - Certain Measures Concerning the Production, Importation and Marketing of Pharmaceutical Products, WT/DS583/ARB25#359277
• Biobanks in the era of personalized medicine: objectives, challenges, and innovation#335754
• A hybrid ML-PBPK digital twin framework for clinically interpretable readmission risk and drug exposure stratification in diabetes.#975640